Expression of hematopoietic growth factor receptors an early hematopoietic precursors: detection and regulation

被引:1
作者
Greenberger, JS [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA 15213 USA
关键词
D O I
10.1097/00062752-200005000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the original isolation of colony-stimulating factors from human serum, conditioned medium of murine or human cell lines, or freshly isolated human mononuclear cells, a revolutionary explosion of ideas has occurred in our understanding of molecular controls of the hematopoietic stem cell self-renewal and differentiation, With the availability of techniques of molecular cloning in the early 1980s, the first hematopoietically activated cytokines led to molecular clones expressed in bacteria, yeast, or mammalian cellular systems. There then followed a development of techniques leading to the molecular cloning and expression of many hematopoietic growth factors and their receptors, as well as the primary, secondary, and tertiary molecules in signal transduction into activation of specific genes for differentiation or self-renewal. The clinical use of these factors in the diagnosis, treatment, and incorporation into new cell therapies for a variety of diseases is a subject of current interest. (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 101 条
[61]   Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+Thy-1+ cells into rapid division [J].
Murray, LJ ;
Young, JC ;
Osborne, LJ ;
Luens, KM ;
Scollay, R ;
Hill, BL .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (06) :1019-1028
[62]   Administration of Flk2/Flt3 ligand induces expansion of human high-proliferative potential colony-forming cells in the SCID-hu mouse [J].
Namikawa, R ;
Muench, MO ;
Firpo, MT ;
Humeau, L ;
Xu, YM ;
Menon, S ;
Roncarolo, MG .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (06) :1029-1037
[63]  
NEMUNAITIS J, 1992, BLOOD, V79, P2572
[64]   Anti-apoptotic function of Rac in hematopoietic cells [J].
Nishida, K ;
Kaziro, Y ;
Satoh, T .
ONCOGENE, 1999, 18 (02) :407-415
[65]   Both stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6 induced apoptosis of 1A9-M cells [J].
Oritani, K ;
Tomiyama, Y ;
Kincade, PW ;
Aoyama, K ;
Yokota, T ;
Matsumura, I ;
Kanakura, Y ;
Nakajima, K ;
Hirano, T ;
Matsuzawa, Y .
BLOOD, 1999, 93 (04) :1346-1354
[66]   MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25) [J].
Osaka, M ;
Rowley, JD ;
Zeleznik-Le, NJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6428-6433
[67]   Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell [J].
Osawa, M ;
Hanada, K ;
Hamada, H ;
Nakauchi, H .
SCIENCE, 1996, 273 (5272) :242-245
[68]   Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody [J].
Oyajobi, BO ;
Lomri, A ;
Hott, M ;
Marie, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (03) :351-361
[69]   Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging [J].
Oyama, M ;
Tatlock, A ;
Fukuta, S ;
Kavalkovich, K ;
Nishimura, K ;
Johnstone, B ;
Robbins, PD ;
Evans, CH ;
Niyibizi, C .
GENE THERAPY, 1999, 6 (03) :321-329
[70]  
Papayannopoulou T, 1998, BLOOD, V92, p152A